Latest News

Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years / image credit Miharu Nakanishi, PhD Courtesy of World Dementia Council
Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years

April 22nd 2025

The findings suggest that women who experience early menopause (age <40 vs >50 years) may constitute a sex-specific high-risk group for cognitive decline.

One in Three Cases of Dementia May be Attributable to Hearing Loss: Population-Based Study
One in Three Cases of Dementia May be Attributable to Hearing Loss: Population-Based Study

April 22nd 2025

FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention
FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention

April 16th 2025

Emergency Care for Cannabis Use May Increase Risk for Dementia in Adults / image credit University of Ottawa
Emergency Care for Cannabis Use Associated with Increased Risk for Dementia in Adults: Canadian Population Study

April 16th 2025

Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock
Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose

April 10th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

View More

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

View More

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Carolina Neuromuscular Disease Summit

September 27, 2025

Register Now!

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

View More

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

View More

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

View More

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

View More

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

View More

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

View More

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

View More

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

View More

Identifying and Treating CIDP in the Modern Era

View More

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

View More

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

View More

Medical Crossfire®: Optimal Approaches to Evaluating and Addressing Pain in the Patient With Sickle Cell Disease

View More

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

View More

More News

© 2025 MJH Life Sciences

All rights reserved.